InMed Pharmaceuticals Inc. (NASDAQ:INM) announced that a peer-reviewed scientific study entitled “Effects of Rare Phytocannabinoids on the Endocannabinoid System of Human Keratinocytes” has been published in the International Journal of Molecular Sciences.
In the peer-reviewed study, researchers analyzed the effects of rare cannabinoids tetrahydrocannabivarin (“THCV”), cannabichromene (“CBC”), cannabigerol (“CBG”) and cannabigerolic acid (“CBGA”) on the major endocannabinoid system elements in skin cells.
